Prospective observational cohort study of bevacizumab combined with paclitaxel as the first- or second-line chemotherapy for locally advanced or metastatic breast cancer (Study JBCRG-C05: B-SHARE)
Kashiwaba, M., Yamamoto, Y., Yamashiro, H., Kondo, N., Nakamura, R., Takahashi, M., Toh, U., Tsugawa, K., Narui, K., Tamaki, K., Yoshinami, T., Ohtani, S., Kai, Y., Takano, T., Yanagita, Y., Morita, SТом:
92
Мова:
english
Журнал:
European Journal of Cancer
DOI:
10.1016/s0959-8049(18)30528-8
Date:
April, 2018
Файл:
PDF, 48 KB
english, 2018
File converter
Більше результатів пошуку
More benefits 
